Roxane Laboratories, Inc. announced today the approval of their Abbreviated New Drug Application for Zaleplon Capsules CIV, 5mg and 10mg. The product is available in bottles of 100 capsules for immediate shipment to wholesalers and pharmacies nationwide.
Roxane Laboratories' Zaleplon Capsules CIV are AB rated to SONATA(R) (zaleplon). Annual sales of SONATA(R) (zaleplon) Capsules CIV are approximately $87.8 Million(1).
No comments:
Post a Comment